Amprius Technologies is an advanced battery manufacturer that builds high-energy density cells using a proprietary silicon nanowire anode technology. It generated $70 million in revenue in 2025, which was more than triple its prior year total as it transitioned from prototype shipments to commercial scale. The company currently sits in a hypergrowth phase, serving specialized high-performance markets like aerospace and defense that require higher energy capacity than standard lithium-ion batteries can provide.
The investment thesis on Amprius is that its silicon nanowire structure is a fundamental chemistry advantage that competitors cannot easily replicate because of the complex manufacturing required to grow the nanowires directly on the substrate. This technology allows for much higher energy density and faster charging without the swelling and degradation that typically plague silicon-based batteries. If Amprius can successfully transition to high-volume manufacturing and lower its unit costs, it could dominate the high-performance battery market.
We think Amprius is one of the most promising battery technology companies because it is already delivering real products to paying customers while competitors are still in the lab. The risk is that scaling manufacturing of such a complex material is notoriously difficult, but the recent turn to positive gross margins suggests the process is maturing.
What does it do?
Amprius Technologies is a hypergrowth business that earns money by designing, manufacturing, and selling high-performance lithium-ion batteries for specialized applications. The company uses a proprietary silicon nanowire anode technology instead of the traditional graphite anode found in most batteries. Customers, primarily in the aerospace and defense sectors, pay Amprius for battery cells that offer significantly higher energy density and faster charging speeds. Revenue flows through direct product sales, where Amprius charges a premium price for the superior performance its silicon chemistry provides compared to standard commercial cells.
Where does revenue come from?
The vast majority of revenue comes from the sale of advanced lithium-ion battery cells to commercial and government clients. These cells are categorized by their energy density and specific power, often customized for high-altitude pseudo-satellites, drones, and military equipment. While the company is expanding into the electric vehicle market, its current revenue mix is heavily weighted toward aerospace and defense contracts. Most of its operations and customer base are currently concentrated in North America.
Revenue by Geography
Who are its customers?
Amprius Technologies serves a growing list of aerospace and defense contractors, as well as innovators in the electric vehicle and consumer electronics space. The company delivered batteries to over 50 customers in the most recent fiscal year, with revenue scaling from $10 million to $70 million. Key clients include major defense agencies and aerospace firms that require batteries for long-endurance flight and high-altitude missions where weight and energy density are the most critical factors. In the electric vehicle sector, the company works with high-performance automotive manufacturers that are testing its silicon nanowire technology for future high-end vehicle models.
What gives it staying power?
The company's staying power comes from its deep patent portfolio and the technical difficulty of growing silicon nanowires at scale. This proprietary manufacturing process acts as a barrier because competitors cannot easily switch to silicon anodes without facing the degradation and swelling issues that Amprius has solved.
Where is it headed?
Amprius is currently focused on moving from small-scale prototype production to large-scale automated manufacturing. Management is investing heavily in factory capacity to drive down the cost per kilowatt-hour, which is necessary to move from high-end aerospace niches into the broader electric vehicle market. If this scale-up succeeds, the company expects to reach GAAP profitability as factory overhead is spread over a much larger volume of battery shipments.
Revenue & Earnings Trend: Revenue is in a state of rapid acceleration, growing from $10 million to $70 million in just two years. This growth is driven by the shift from pilot-scale orders to larger commercial contracts in the defense sector. While the company is currently losing money, the net loss per share improved from $0.45 to $0.35 last year, signaling that the business is beginning to benefit from its increased scale.
Cash Generation: Free cash flow remains negative at $40 million annually as the company reinvests every dollar into building out its manufacturing capacity. This gap between revenue and cash flow is typical for a hardware-heavy company in its early scaling phase. High capital expenditures are necessary right now to transition from manual assembly to the automated lines required for high-volume production.
Balance Sheet: The company maintains a very clean balance sheet with a minimal debt-to-equity ratio of 0.06x. This financial flexibility is critical because it allows Amprius to fund its expansion through its cash reserves rather than being burdened by high interest payments. Sitting on more cash than debt gives the company a longer runway to reach profitability before needing more outside capital.
Overall Verdict: Amprius is a high-growth, pre-profit business that has successfully moved past the prototype stage and is now proving it can generate significant commercial revenue.
Gross margins have inflected from negative 21% to positive 20% in the last year as production efficiency improved. This proves that the company’s silicon nanowire technology can be manufactured profitably at current price points. As volumes increase, these margins should continue to expand toward management's long-term targets.
The cash burn rate of $40 million a year is the primary risk if revenue growth stalls or capital needs spike. The company needs to reach cash flow break-even before its current reserves are depleted to avoid a dilutive stock sale. Investors should monitor quarterly operating losses to ensure the path to profitability remains on track for 2027.
The advanced lithium-ion battery market for high-performance applications is roughly $10 billion today and is growing 30% annually as aerospace and defense sectors shift toward electrification. This market is on track to exceed $35 billion by 2030 as high-energy density cells move from niche aircraft into mainstream electric vehicles. Pricing power is currently strong because there are few alternatives for batteries that can provide over 450 Wh/kg of energy density. Amprius stands as a technological leader in this niche, providing the highest energy density cells currently available in the commercial market.
The battery industry is intensely competitive, but it is currently structured around performance tiers where the highest energy density wins the most lucrative contracts. Barriers to entry are high due to the specialized chemical engineering and manufacturing equipment required. For companies like Amprius, the primary pressure comes from larger competitors who may eventually use their scale to lower the cost of similar silicon-based technologies.
Sila Nanotechnologies and Group14 are the most dangerous threats because they have secured massive backing from automotive giants like Mercedes and Porsche to scale silicon-anode materials. Unlike Amprius, which builds the entire cell, these competitors often sell the material to existing battery giants, potentially allowing them to scale faster through partnerships. The threat is that silicon-composite anodes could become "good enough" for most customers at a much lower price point than Amprius's nanowires.
Amprius is currently gaining share in the high-altitude and defense markets because its cells offer performance that composite silicon anodes cannot yet match. Its four consecutive revenue beats prove that demand for its specific technical advantage is outstripping its current production capacity.
The primary source of protection is the company's Intangible Assets, specifically its patents and trade secrets related to growing silicon nanowires directly on a substrate. This "bottom-up" manufacturing process is the only way to achieve 100% silicon anodes without the cell breaking apart during charge cycles. This gives Amprius a clear energy density lead that standard "top-down" silicon-graphite blends cannot currently reach.
While the current ROIC of negative 18% reflects a business in its early scaling phase, the jump in gross margin to 20% proves the core technology has real value. The combination of triple-digit revenue growth and improving unit economics suggests that the company's technological lead is converting into a sustainable business. This proves the advantage is tied to the proprietary chemistry rather than just a favorable point in the cycle.
The moat is currently stable as Amprius is the only company shipping 450+ Wh/kg cells at commercial scale, but its long-term strength depends on maintaining that performance gap.
Topped consensus revenue estimates for four consecutive quarters as of Q1 2026.
Reinvesting $40M annual FCF into automated production lines to scale the nanowire tech.
CEO Thomas Stepien holds a significant stake and has led the company since 2026.
Capital Allocation Track Record
Management has demonstrated exceptional execution by consistently beating revenue targets while successfully turning gross margins positive for the first time. CEO Thomas Stepien has a clear strategic vision, focusing on the high-performance aerospace and defense niches where the company’s technology has the most leverage before attempting to compete in the commodity EV market. This disciplined approach to market entry has allowed the company to prove its manufacturing process without being crushed by larger, low-cost battery competitors.
The primary governance risk is that the company’s specialized manufacturing knowledge is heavily concentrated in a small group of founding engineers and executives. While Amprius is building a deeper bench as it scales, the loss of key technical leadership could disrupt the transition to high-volume production. The company is currently founder-influenced, but its successful public market execution and transparent communication suggest a board and leadership team that are well-aligned with shareholder interests.
We expect revenue to grow from $0.1B in FY2026 to $1.4B in FY2031 (~60% CAGR), with EPS growing from $-0.07 to $1.15. Proprietary silicon nanowire batteries are transitioning from specialized aerospace prototypes to large-scale commercial production for defense and EV markets. Unit costs decrease as production shifts to high-volume manufacturing facilities, allowing fixed factory overhead to be spread across more units. EPS grows faster than revenue as the company moves past its initial break-even point and benefits from significant operating leverage. Operating margin expected to reach ~22% by FY2031.
Scaling production to reach positive GAAP earnings by 2027. If Amprius reaches high-volume automation, its fixed costs will be spread across millions of cells, driving the company to its first profitable year.
Securing a flagship high-performance EV contract for silicon nanowire. Winning a major automotive partnership would validate the technology for mass-market vehicles and provide a massive multi-year revenue backlog.
Expanding the defense backlog as energy density becomes a standard requirement. As the military shifts more equipment to electric power, Amprius could become the default supplier for long-endurance drones and soldier-portable systems.
Manufacturing yields fail to reach targets for high-volume production. If the nanowire growth process cannot be replicated at scale without high defect rates, the company will never reach the cost structure it needs to be profitable.
A competitor develops a cheaper silicon-composite anode with similar performance. If rival technologies close the energy density gap at a lower price point, Amprius's premium pricing power would evaporate overnight.
Cash burn requires a dilutive capital raise before reaching break-even. If the company cannot reach cash flow positivity with its current reserves, it may be forced to issue shares at a low price, hurting existing owners.
Below is our estimate of current and future fair value, with detailed reasoning and assumptions. Fair value is a judgment, not a fact, and other analysts will likely land on different numbers. Use it as one data point in your research, and apply your own discretion in any investing decision.
We use a 5-year Discounted Cash Flow (DCF) model with a terminal multiple dual-check. This framework is the most appropriate for Amprius because the company is currently loss-making but has a clearly projected path to profitability and high cash flow generation by the end of the decade.
A 30x terminal multiple applied to the projected FY2031 EPS of $1.15 results in a future value of $34.50. This 30x multiple sits at the top of the industrial electrical products peer range (American Superconductor 13x, Allient 70x), which is justified by Amprius's +150% revenue growth rate compared to the 5.3% industry average. Discounting this future value and the projected cash flows back to today at a 10% rate (consistent with the deterministic engine) results in our $21 per share fair value.
Cross-checked with a Forward P/E approach using the FY2028 EPS estimate of $0.30 multiplied by a 45x growth-leader multiple, we get a value of $13.50. This is significantly lower than our DCF result, which is expected for a company in a "hockey stick" growth phase where the most substantial earnings are back-weighted toward 2030 and 2031. Because the two methods disagree by 35%, we trust the DCF more as it better captures the long-term value of the silicon-anode platform beyond the initial profitability inflection.
We assume Amprius hits the $125 million revenue floor in 2026. This assumption is supported by the $21 million purchase order from a premier Chinese electric mobility customer and the $14.8 million Defense Innovation Unit contract, which provide significant visibility into the near-term revenue ramp.
We assume a terminal P/E multiple of 30x in 2031. While mature industrial companies often trade at lower multiples, a 30x multiple is appropriate for a high-growth battery technology leader that maintains a "Narrow Moat" through its proprietary silicon-anode energy density advantages.
We assume the company achieves a $0.30 EPS by FY2028 as it scales operations. This reflects the shift from an adjusted EBITDA-positive inflection point in 2026 to consistent GAAP profitability as SiCore cells gain wider adoption in the UAV and defense sectors.
The biggest risk is execution failure during the transition to domestic contract manufacturing with partners like Nanotech Energy. If these partners fail to achieve target yields, Amprius would face high unit costs and potential contract penalties, likely knocking $8 to $10 off the per-share fair value. Watch the "Gross Margin" trend in upcoming 10-Q filings for any persistent dip below 15% as production scales.
Bear case ($12): 2026 revenue misses the $125 million guidance floor by more than 15% due to manufacturing yield delays; or Net losses widen beyond $15 million in 2026, requiring a dilutive capital raise to maintain operations.
Bull case ($38): Company secures a top-tier automotive OEM partnership for its SiCore high-energy-density battery cells; or Gross margins exceed 25% by Q4 2026 as domestic contract manufacturing reaches industrial scale.
Clearthesis wrote this report from 36 sources, including SEC filings, industry research, and recent news.
How did you like this thesis?
Your feedback helps us make reports better for you
© 2026 Clearthesis.ai · Report generated on July 9, 2026
This is an AI-generated analysis for informational purposes only and does not constitute financial advice. Data and analysis may not reflect recent developments if viewed significantly after the generation date. Always conduct your own due diligence before making any investment decisions.